Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.

Abraham NG, Junge JM, Drummond GS.

Trends Pharmacol Sci. 2016 Jan;37(1):17-36. doi: 10.1016/j.tips.2015.09.003. Epub 2015 Oct 26. Review.

2.

Heme oxygenase: a target gene for anti-diabetic and obesity.

Abraham NG, Tsenovoy PL, McClung J, Drummond GS.

Curr Pharm Des. 2008;14(5):412-21. Review.

PMID:
18289068
3.

Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats.

L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond GS, McClung JA, Abraham NG.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3532-41. Epub 2007 Sep 28.

4.

Chemoprevention of severe neonatal hyperbilirubinemia.

Drummond GS, Kappas A.

Semin Perinatol. 2004 Oct;28(5):365-8. Review.

PMID:
15686268
5.

Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).

Martínez JC, García HO, Otheguy LE, Drummond GS, Kappas A.

J Perinatol. 2001 Dec;21 Suppl 1:S101-3; discussion S104-7. No abstract available.

6.
7.
8.

Adenoviral vector-mediated transfer of human heme oxygenase in rats decreases renal heme-dependent arachidonic acid epoxygenase activity.

Abraham NG, Jiang S, Yang L, Zand BA, Laniado-Schwartzman M, Marji J, Drummond GS, Kappas A.

J Pharmacol Exp Ther. 2000 May;293(2):494-500.

9.

Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man.

Berglund L, Galbraith RA, Emtestam L, Drummond GS, Angelin B, Kappas A.

Pharmacology. 1999 Jul;59(1):51-6.

PMID:
10352426
10.

Pharmacologic effects of the red blood cell substitutes cross-linked and non-cross-linked hemoglobins on hematopoiesis in rabbits.

Lutton JD, Jiang S, Drummond GS, Abraham NG, Levere RD, Kappas A.

Pharmacology. 1999 Jun;58(6):319-24.

PMID:
10325577
11.

Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.

Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A.

Pediatrics. 1999 Jan;103(1):1-5.

PMID:
9917431
12.
14.
15.

Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow.

Lutton JD, Abraham NG, Drummond GS, Levere RD, Kappas A.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1432-6.

16.

Control of bilirubin production by synthetic heme analogs: pharmacologic and toxicologic considerations.

Drummond GS, Valaes T, Kappas A.

J Perinatol. 1996 May-Jun;16(3 Pt 2):S72-9. Review. No abstract available.

PMID:
8817443
17.

Tissue distribution of synthetic heme analogues: studies with tin, chromium, and zinc mesoporphyrins.

Bundock EA, Drummond GS, Kappas A.

Pharmacology. 1996 Mar;52(3):187-98.

PMID:
8849488
18.

Effects of a series of metalloporphyrins on adrenal, testicular and thyroid function in rats.

Drummond GS, Smith TJ, Kappas A.

Pharmacology. 1996 Mar;52(3):178-86.

PMID:
8849487
19.

Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements.

Lavrovsky Y, Drummond GS, Abraham NG.

Biochem Biophys Res Commun. 1996 Jan 26;218(3):759-65.

PMID:
8579587
22.

Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.

Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A.

Pediatrics. 1994 Jan;93(1):1-11.

PMID:
8265301
23.

Tin-mesoporphyrin inhibits heme oxygenase activity and heme-iron absorption in the intestine.

Böni RE, Huch Böni RA, Galbraith RA, Drummond GS, Kappas A.

Pharmacology. 1993 Nov;47(5):318-29.

PMID:
8265722
24.

Investigations on the role of hemopexin and albumin in plasma clearance and tissue distribution of Sn-protoporphyrin.

Simionatto CS, Drummond GS, Landaw SA, Kappas A, Liem H, Vincent S, Muller-Eberhard U.

J Lab Clin Med. 1993 Aug;122(2):173-9.

PMID:
8340702
25.

Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.

Cannon JB, Martin C, Drummond GS, Kappas A.

Pharm Res. 1993 May;10(5):715-21.

PMID:
8321837
26.
27.

Photodynamic properties of Sn-protoporphyrin: clinical investigations and phototesting in human subjects.

Emtestam L, Angelin B, Berglund L, Drummond GS, Kappas A.

Acta Derm Venereol. 1993 Feb;73(1):26-30.

PMID:
8095746
28.

Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins.

Drummond GS, Rosenberg DW, Kappas A.

Gastroenterology. 1992 Apr;102(4 Pt 1):1170-5.

PMID:
1551526
29.
30.
31.
32.

Induction of heme oxygenase mRNA by cobalt protoporphyrin in rat liver.

Smith TJ, Haque S, Drummond GS.

Biochim Biophys Acta. 1991 Jan 23;1073(1):221-4.

PMID:
1991140
33.
34.
35.

Tin-protoporphyrin and long wave length ultraviolet light in treatment of psoriasis.

Emtestam L, Berglund L, Angelin B, Drummond GS, Kappas A.

Lancet. 1989 Jun 3;1(8649):1231-3.

PMID:
2566782
36.

Control of heme catabolism by Sn-protoporphyrin.

Drummond GS.

Semin Hematol. 1989 Jan;26(1):24-6. Review. No abstract available.

PMID:
2646721
38.

The in vitro and in vivo inhibition of intestinal heme oxygenase by tin-protoporphyrin.

Rosenberg DW, Drummond GS, Kappas A.

Pharmacology. 1989;39(4):224-9.

PMID:
2608721
39.

Thyroid hormone regulation of heme synthesis in rat liver.

Smith TJ, Drummond GS.

Endocrinology. 1988 May;122(5):1964-7.

PMID:
3359971
40.

Photophysical properties of Sn-porphyrins: potential clinical implications.

Delaney JK, Mauzerall D, Drummond GS, Kappas A.

Pediatrics. 1988 Apr;81(4):498-504.

PMID:
3353183
41.

Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility.

Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T.

Pediatrics. 1988 Apr;81(4):485-97.

PMID:
3281127
42.

Sn-protoporphyrin blocks the increase in serum bilirubin levels that develops postnatally in homozygous Gunn rats.

Sisson TR, Drummond GS, Samonte D, Calabio R, Kappas A.

J Exp Med. 1988 Mar 1;167(3):1247-52.

43.
45.
47.

Control of heme metabolism by synthetic metalloporphyrins.

Drummond GS.

Ann N Y Acad Sci. 1987;514:87-95. No abstract available.

PMID:
3442392
48.

Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans.

Anderson KE, Simionatto CS, Drummond GS, Kappas A.

Clin Pharmacol Ther. 1986 May;39(5):510-20.

PMID:
3698459

Supplemental Content

Loading ...
Support Center